Increased adenosine A 2A receptors in the brain of Parkinson’s disease patients with dyskinesias

Author： Calon Frédéric  

Publisher： Oxford University Press

ISSN： 1460-2156

Source： Brain, Vol.127, Iss.5, 2004-05, pp. : 1075-1084

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapy for dyskinesias in Parkinson’s disease patients

By Stefani Alessandro   Pierantozzi Mariangela   Koch Giacomo   Galati Salvatore   Stanzione Paolo  

Future Neurology, Vol. 5, Iss. 2, 2010-03 ,pp. : 277-299

Future Medicine

Access to resources Recommend Favorite

The influence of levodopa-induced dyskinesias on manual tracking in patients with Parkinson’s disease

By Lemieux Sarah   Ghassemi Mehrdad   Jog Mandar   Edwards Roderick   Duval Christian  

Experimental Brain Research, Vol. 176, Iss. 3, 2007-01 ,pp. : 465-475

Springer Publishing Company

Access to resources Recommend Favorite

Motor fluctuations and dyskinesias in advanced/end stage Parkinson’s disease: a study from a population of brain donors

By Papapetropoulos S.   Mash D. C.  

Journal of Neural Transmission, Vol. 114, Iss. 3, 2007-03 ,pp. : 341-345

Springer Publishing Company

Access to resources Recommend Favorite

Preladenant: an adenosine A2A receptor antagonist for Parkinson’s disease

By Zúñiga-Ramírez Carlos   Micheli Federico  

Future Neurology, Vol. 8, Iss. 6, 2013-11 ,pp. : 639-648

Future Medicine

Access to resources Recommend Favorite

Force overflow and levodopa-induced dyskinesias in Parkinson’s disease

By Wenzelburger R.   Zhang B-R.   Pohle S.   Klebe S.   Lorenz D.   Herzog J.   Wilms H.   Deuschl G.   Krack P.  

Brain, Vol. 125, Iss. 4, 2002-04 ,pp. : 871-879

Oxford University Press

Access to resources Recommend Favorite